Rare diseases
Investigational molecules
Locations
Back to Germany607 clinical trials in Tuebingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Bevacizumab for Patients with Newly Diagnosed IDH Wild-Type, MGMT Unmethylated Glioblastoma
GermanyStudy on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis
GermanyStudy on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery
GermanyStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
GermanyStudy on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System
GermanyStudy Comparing Teclistamab with Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy of Troriluzole and ADI-PEG-20 for Patients with Newly Diagnosed and Recurrent Glioblastoma
GermanyStudy on the Safety and Effectiveness of rAAV.hCNGA3 for Adults and Minors with CNGA3-Linked Achromatopsia
GermanyStudy on the Safety and Effectiveness of LT3001 for Patients with Acute Ischemic Stroke
GermanyStudy Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients
GermanyGermanyStudy Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on cutaneous lupus erythematosus and psoriatic arthritis, evaluating novel therapeutic approaches for managing chronic inflammatory conditions.
Studies aim to assess new treatment options for improving patient outcomes and quality of life.
Comprehensive studies on various cancer types, including metastatic prostate cancer and basal cell carcinoma, exploring innovative treatment combinations.
Research focuses on improving survival rates and developing more effective treatment strategies.
Groundbreaking research in multiple system atrophy and seizure disorders, investigating new therapeutic approaches for complex neurological conditions.
Clinical trials aim to enhance treatment options for patients with challenging neurological conditions.
Advanced research in eye disorders, including Leber congenital amaurosis and geographic atrophy, focusing on innovative treatment approaches.
Trials aim to preserve and improve vision in patients with rare and progressive eye conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
